Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_assertion type Assertion NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_head.
- NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_assertion description "[Moreover, the higher expression level of DCLK1 in patients undergoing CRT can propose it as a more relevant candidate among CSC markers comparing to Lgr5 for CRC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_provenance.
- NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_assertion evidence source_evidence_literature NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_provenance.
- NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_assertion SIO_000772 25631749 NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_provenance.
- NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_assertion wasDerivedFrom befree-2016 NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_provenance.
- NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_assertion wasGeneratedBy ECO_0000203 NP1259239.RAaYh4xMXuKOuRloRU6JGuJcYY2-4I_WBlTNSmZYuSwic130_provenance.